Logo image of SSY

SUNLINK HEALTH SYSTEMS INC (SSY) Stock Fundamental Analysis

NYSEARCA:SSY - NYSE Arca - US86737U1025 - Common Stock - Currency: USD

0.8801  -0.02 (-2.21%)

Fundamental Rating

4

SSY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 105 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for SSY as it has an excellent financial health rating, but there are worries on the profitability. SSY has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

SSY had positive earnings in the past year.
SSY had a negative operating cash flow in the past year.
SSY had negative earnings in 4 of the past 5 years.
In multiple years SSY reported negative operating cash flow during the last 5 years.
SSY Yearly Net Income VS EBIT VS OCF VS FCFSSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

With an excellent Return On Assets value of 5.60%, SSY belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
SSY's Return On Equity of 7.10% is fine compared to the rest of the industry. SSY outperforms 65.71% of its industry peers.
Industry RankSector Rank
ROA 5.6%
ROE 7.1%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SSY Yearly ROA, ROE, ROICSSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

SSY has a better Profit Margin (3.20%) than 67.62% of its industry peers.
The Gross Margin of SSY (42.96%) is better than 71.43% of its industry peers.
SSY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 3.2%
GM 42.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
SSY Yearly Profit, Operating, Gross MarginsSSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

SSY does not have a ROIC to compare to the WACC, probably because it is not profitable.
SSY has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SSY has more shares outstanding
There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SSY Yearly Shares OutstandingSSY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M
SSY Yearly Total Debt VS Total AssetsSSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.75 indicates that SSY is not a great score, but indicates only limited risk for bankruptcy at the moment.
SSY has a better Altman-Z score (2.75) than 61.90% of its industry peers.
SSY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.75
ROIC/WACCN/A
WACC9.05%
SSY Yearly LT Debt VS Equity VS FCFSSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 4.06 indicates that SSY has no problem at all paying its short term obligations.
SSY's Current ratio of 4.06 is amongst the best of the industry. SSY outperforms 91.43% of its industry peers.
A Quick Ratio of 3.62 indicates that SSY has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.62, SSY belongs to the top of the industry, outperforming 91.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 3.62
SSY Yearly Current Assets VS Current LiabilitesSSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

SSY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.95%, which is quite impressive.
The Revenue for SSY has decreased by -21.10% in the past year. This is quite bad
The Revenue has been decreasing by -6.58% on average over the past years.
EPS 1Y (TTM)116.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.81%
Revenue 1Y (TTM)-21.1%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-6.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSY Yearly Revenue VS EstimatesSSY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 5.50 indicates a rather cheap valuation of SSY.
Compared to the rest of the industry, the Price/Earnings ratio of SSY indicates a rather cheap valuation: SSY is cheaper than 97.14% of the companies listed in the same industry.
SSY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.64.
Industry RankSector Rank
PE 5.5
Fwd PE N/A
SSY Price Earnings VS Forward Price EarningsSSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SSY Per share dataSSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SSY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNLINK HEALTH SYSTEMS INC

NYSEARCA:SSY (4/24/2025, 12:01:26 PM)

0.8801

-0.02 (-2.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-18 2025-02-18
Earnings (Next)05-14 2025-05-14
Inst Owners14.13%
Inst Owner Change0%
Ins Owners23.27%
Ins Owner Change0%
Market Cap6.20M
Analysts0
Price TargetN/A
Short Float %0.75%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.5
Fwd PE N/A
P/S 0.2
P/FCF N/A
P/OCF N/A
P/B 0.44
P/tB 0.48
EV/EBITDA N/A
EPS(TTM)0.16
EY18.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS4.44
BVpS2
TBVpS1.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.6%
ROE 7.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.2%
GM 42.96%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
F-Score4
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.71%
Cap/Sales 3.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.06
Quick Ratio 3.62
Altman-Z 2.75
F-Score4
WACC9.05%
ROIC/WACCN/A
Cap/Depr(3y)133.35%
Cap/Depr(5y)134.66%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.1%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-6.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-451.48%
OCF growth 3YN/A
OCF growth 5YN/A